Anti-spam Policy

Psychopharmacomania prohibits the use of their website and/or services in any manner associated with the transmission, distribution or delivery of any unsolicited bulk or unsolicited commercial e-mail (“Spam”). You may not use any Psychopharmacomania services to send Spam. You also may not deliver Spam or cause Spam to be delivered to any customers of Association Of Dog Whisperers.

In compliance with the CAN-SPAM Act of 2003 (15 U.S.C. 7701, et seq., Public Law No. 108-187, was S.877 of the 108th United States Congress), e-mail sent, or caused to be sent, to or through the Psychopharmacomania webiste or service may not:

  • use or contain invalid or forged headers;
  • use or contain invalid or non-existent domain names;
  • employ any technique to otherwise misrepresent, hide or obscure any information in identifying the point of origin or the transmission path;
  • use other means of deceptive addressing;
  • use a third party’s internet domain name, or be relayed from or through a third party’s equipment, without permission of the third party;
  • contain false or misleading information in the subject line or otherwise contain false or misleading content;
  • fail to comply with additional technical standards described below;
  • otherwise violate our Terms of Use.

Psychopharmacomania does not authorize the harvesting, mining or collection of e-mail addresses or other information from or through the website or its services. Association Of Dog Whisperers does not permit or authorize others to use the Psychopharmacomania services to collect, compile or obtain any information about its customers or subscribers, including but not limited to subscriber e-mail addresses.

Psychopharmacomania does not permit or authorize any attempt to use its services in a manner that could damage, disable, overburden or impair any aspect of any of the services, or that could interfere with any other party’s use and enjoyment of any Psychopharmacomania service.

If Psychopharmacomania believes that unauthorized or improper use is being made of any service, it may, without notice, take such action as it, in its sole discretion, deems appropriate, including blocking messages from a particular internet domain, mail server or IP address. Psychopharmacomania may immediately terminate any account on any service which it determines, in its sole discretion, is transmitting or is otherwise connected with any e-mail that violates this policy.

Nothing in this policy is intended to grant any right to transmit or send e-mail to, or through, the Psychopharmacomania website and/or services. Failure to enforce this policy in every instance does not amount to a waiver of Psychopharmacomania rights.

Unauthorized use of any Psychopharmacomania services in connection with the transmission of unsolicited e-mail, including the transmission of e-mail in violation of this policy, may result in civil, criminal, or administrative penalties against the sender and those assisting the sender.

Violators of the CAN SPAM Act may be subject to “cease and desist” orders or penalties from the FTC (Federal Trade Commission) of up to $11,000 per violation. Criminal prosecution is also possible in the case of egregious offenders, which can result in penalties such as fines, forfeiture of proceeds and equipment. The worst offenders can also be subject to prison time.

Comments are closed.

What Is Pharmacomania

Pharmacomania as defined by Webster's dictionary: An uncontrollable desire to administer drugs. A morbid impulse to take drugs. A craze for using or trying drugs. A chronic fascination with medicines. A mania for medicines. Pharmacomania causes Psychopharmacomania

What Is Psychopharmacomania ™

Psychopharmacomania is a mental or emotional disorder caused by the ingestion of too much end-product of the psychopharmacological digestive tract. It results in varying degrees of intractable depression, permanent psychosis, and brain damage depending on which drug rep reaches your doctor first.

More About Psychopharmacomania ™

Drug reps frequent doctors’ offices, take them out to dinner, give them enticements to interest them in their products. They target non-psychiatrists, in hopes that every primary care physician will know exactly what to prescribe for their patients. They educate them with psychopharmacological babble.